MARKET

SNCA

SNCA

Seneca Biopharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.7398
+0.0085
+1.16%
Closed 18:51 07/06 EDT
OPEN
0.7340
PREV CLOSE
0.7313
HIGH
0.7599
LOW
0.7260
VOLUME
339.72K
TURNOVER
--
52 WEEK HIGH
9.89
52 WEEK LOW
0.5000
MARKET CAP
12.80M
P/E (TTM)
-0.2182
1D
5D
1M
3M
1Y
5Y

Analyst Price Target

The average SNCA stock price target is 26.00 with a high estimate of 26.00 and a low estimate of 26.00.

EPS

SNCA News

More
Penny Stocks to Buy Using Technical Analysis for June 2020
These low-priced stocks may prove exempt from a potential downtrend based on their bullish technical signals.
Investopedia · 05/29 16:14
Seneca Biopharma Announces the Closing of its $5 Million Registered Direct Offering
PR Newswire · 05/27 16:00
Seneca down 24% on capital raise, warrant exercises
Seeking Alpha - Article · 05/22 16:36
Seneca Biopharma Announces Pricing of $5 Million Registered Direct Offering Priced At-the-Market
PR Newswire · 05/22 14:24
64 Biggest Movers From Yesterday
Gainers
Benzinga · 05/22 09:26
51 Stocks Moving In Thursday's Mid-Day Session
Gainers Seneca Biopharma, Inc. (NASDAQ: SNCA) jumped 99% to $1.6350.
Benzinga · 05/21 17:18
28 Stocks Moving in Thursday's Pre-Market Session
Gainers Aurora Cannabis Inc. (NYSE: ACB) shares rose 34.1% to $17.10 in pre-market trading after the company announced plans to acquire CBD platform Reliva for $40 million in Aurora common shares.
Benzinga · 05/21 11:17
Seneca Biopharma reports Q1 results
Seneca Biopharma (NASDAQ:SNCA): Q1 GAAP EPS of -$0.93. Revenue of $6.02K (+140.8% Y/Y) Press Release
seekingalpha · 05/15 17:05

Industry

Biotechnology & Medical Research
+0.67%
Pharmaceuticals & Medical Research
+0.72%

Hot Stocks

Symbol
Price
%Change

About SNCA

Seneca Biopharma, Inc., formerly Neuralstem, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for diseases of unmet medical need. It is focused on finding and acquiring new assets, sciences and technologies that provide therapies for patients. It intends to focus on developing a pipeline of biopharmaceuticals and commercializing those products.
More

Webull offers kinds of Seneca Biopharma Inc stock information, including NASDAQ:SNCA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNCA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SNCA stock methods without spending real money on the virtual paper trading platform.